Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-21-017033

Chief Financial Officer acquired 45,258 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Koppikar Utpal Chief Financial Officer 2021-03-01 Grant or award +45,258 175,804 D
Derivatives
Koppikar Utpal Chief Financial Officer 2021-03-01 Grant or award · Employee Stock Option (Right to Buy) +68,314 68,314 D
Loading xslF345X03/doc4.xml…